Drug Repurposing for Primary Amebic Meningoencephalitis (PAM)

Primary Amebic Meningoencephalitis (PAM) is a rare, rapidly fatal infection caused by Naegleria fowleri.
This project focuses on computational drug repurposing to identify FDA-approved compounds with potential inhibitory activity against key PAM target proteins.


---

ğŸ” Project Objectives

Identify druggable target proteins associated with PAM

Prepare structure and ligand datasets

Perform molecular dockingâ€“based virtual screening

Run molecular dynamics (MD) simulations for top hits

Calculate binding affinity (MM/GBSA or similar)

Rank and prioritize repurposable drug candidates

-----

ğŸ§ª Methodology

1. Protein Preparation

Obtained target protein structure (PDB)

Removed water molecules

Added hydrogens and assigned charges

Energy minimized


2. Ligand Library

FDA-approved drugs downloaded from public databases

Converted to .pdbqt format

Energy minimized


3. Molecular Docking

Performed using AutoDock Vina / PyRx

Set exhaustiveness and grid parameters appropriately

Selected top compounds based on binding affinity


4. Molecular Dynamics Simulations

Performed MD using GROMACS

Proteinâ€“ligand complexes were solvated and neutralized

100 ns simulation

RMSD, RMSF, Rg, H-bond analysis performed


5. Binding Energy Analysis

MM/GBSA calculations

Identified most stable proteinâ€“ligand complexes



---

ğŸ“ Project Structure

â”œâ”€â”€ data/        # Protein structures, ligand libraries
â”œâ”€â”€ scripts/     # Docking and MD scripts
â”œâ”€â”€ results/     # Docking results, MD outputs
â””â”€â”€ docs/        # Method notes, workflow documentation


---

ğŸ§¬ Tools Used

AutoDock Vina
MAESTRO
PyMOL
Alphafold



---

ğŸš€ Status

This repository is a work in progress. Experimental files (docking results, MD trajectories, scripts) will be uploaded soon.


---

ğŸ‘¤ Author

Adithya Nair
MSc Molecular Biology
GitHub: your username
LinkedIn: your link
